Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
2018 · New England Journal of Medicine · 2,320 citations
https://doi.org/10.1056/nejmoa1804710
E
Elizabeth Claire Dees
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
407
Papers
15.5K
Citations
45
h-index
107
i10-index
Elizabeth Claire Dees is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Cancer Treatment and Pharmacology. The author has an h-index of 45, co-authored 346 publications.
ORCID: 0000-0003-4004-7316Papers by this author
worksThe Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
2007 · Clinical Cancer Research · 2,097 citations
https://doi.org/10.1158/1078-0432.ccr-06-1109
Phase I Safety, Pharmacokinetics, and Clinical Activity Study of Lapatinib (GW572016), a Reversible Dual Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinases, in Heavily Pretreated Patients With Metastatic Carcinomas
2005 · Journal of Clinical Oncology · 622 citations
https://doi.org/10.1200/jco.2005.16.584
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
2019 · New England Journal of Medicine · 538 citations
https://doi.org/10.1056/nejmoa1904819
The Product of the <i>H19</i> Gene May Function as an RNA
1990 · Molecular and Cellular Biology · 382 citations
https://doi.org/10.1128/mcb.10.1.28-36.1990
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial
2020 · JNCI Journal of the National Cancer Institute · 110 citations
https://doi.org/10.1093/jnci/djaa148
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat